SecBot SecBot
PRESS-RELEASE ·Filed Jun 30, 2026

CELZ

Creative Medical Technology Holdings, Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed3mo ago WireGlobeNewswire
Press release · Dividend
Actionable Insight ▼ Bearish

The warrant exercise and new warrant issuance create significant dilution. Traders should expect near-term selling pressure as shares from warrant exercises enter the market. Monitor the shareholder vote on new warrants for further downside risk.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
CELZ ▼ -32.84% at T+60d
SHORT call ✓ call won +32.84% · α vs SPY +36.40% · entry $1.45 → $0.9738
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
-12.41%
call +12.41% · α +12.28%
$1.27
settled 4mo ago
T+5d
-20.69%
call +20.69% · α +21.29%
$1.15
settled 4mo ago
T+20d
-45.29%
call +45.29% · α +44.26%
$0.7933
settled 3mo ago
T+60d
-32.84%
call +32.84% · α +36.40%
$0.9738
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Creative Medical Technology Holdings raised approximately $4.5 million by inducing immediate exercise of existing warrants at a reduced price of $1.60/share, and issued new warrants for up to 5.58 million shares. The offering is highly dilutive given the company's $3 million market cap, indicating urgent cash needs and pressuring the stock.

Key Financial Metrics

Deal Value
$4.5M

Key Facts

  • Gross proceeds of ~$4.5M from immediate exercise of 2,790,340 warrants at $1.60/share
  • Issued new warrants for up to 5,580,680 shares at $1.60, subject to shareholder approval
  • Market cap is approximately $3M, making the offering size 1.5x market cap
  • Proceeds used for working capital and general corporate purposes

Financial Impact

Gross proceeds of $4.5M with new warrants adding up to 5.58M shares potential dilution

dilutioncash

Risk Factors

  • Massive dilution from new warrants (up to 5.58M shares)
  • Low market cap relative to offering size suggests financial distress
  • Potential for further capital raises

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3320064
9 reports for CELZ
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CELZ — sortable, filterable
TypeNow
Oct 1, 2026
25d ago
SC 13D
NEUTRAL ★ 4/10
$0.9464 $0.9200▼ −2.79%▼ −3.46%$0.7120 (−24.77%)
Sep 25, 2026
4w ago
8-K
MIXED ★ 5/10
$1.01 $0.9652▼ −4.44%▼ −4.25%$0.7120 (−29.50%)
Sep 17, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$0.8775 $0.9659▲ +10.07%▲ +10.19%$0.7120 (−18.86%)
Aug 20, 2026
9w ago
Press Release
NEUTRAL ★ 5/10
$1.28 $1.31▲ +2.34%▲ +1.93%$0.7120 (−44.37%)
Jul 1, 2026
16w ago
Press Release
NEUTRAL ★ 3/10
$1.27 $1.21▼ −4.72%▼ −4.59%$0.7120 (−43.94%)
Jun 30, 2026
16w ago
Press Release
BEARISH ★ 7/10
$1.45 $1.27▲ +12.41%▲ +12.28%$0.7120 (+50.90%)
Jun 26, 2026
17w ago
S-1/A
BEARISH ★ 6/10
$0.8102 $1.45▼ −78.97%▼ −78.19%$0.7120 (+12.12%)
Jun 25, 2026
17w ago
S-1
NEUTRAL ★ 5/10
$1.20 $0.8102▼ −32.48%▼ −34.13%$0.7120 (−40.67%)
Jun 22, 2026
18w ago
Press Release
BULLISH ★ 6/10
$1.93 $1.97▲ +2.07%▲ +3.52%$0.7120 (−63.11%)
Showing 9 of 9

US Market Status

Market Closed — Opens in 3h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026